Schistosomiasis
Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.
Subtype terms (4)
More specific conditions that are subtypes of Schistosomiasis in the MeSH hierarchy.
- Neuroschistosomiasis
- Schistosomiasis haematobia
14 drugs (7 approved, 7 experimental)
- Schistosomiasis japonica
1 drug approved
- Schistosomiasis mansoni
5 drugs (2 approved, 3 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (3)
Phase 3 trials (1)
Phase 2 trials (8)
Organizations
Organization Involved with Phase 4 Indications (10)
- National Institute of Allergy and Infectious Diseases (NIAID)
- World Health Organization
- University of Toronto
- Navrongo Health Research Centre, Ghana
- University of Copenhagen
- University of Basel
- Leiden University
- Federal University of Pernambuco
- Medical Research Council-UVRI Uganda Research Unit on AIDS
- Oswaldo Cruz Foundation
Organization Involved with Phase 3 Indications (19)
- Merck Serono
- Merck KGaA
- Hikma
- Pharco Pharmaceuticals
- Institut National de la Santé Et de la Recherche Médicale, France
- Institute of Tropical Medicine, Belgium
- Jiangsu Institute of Parasitic Diseases
- University of Khartoum
- Aalborg University
- Centre de Recherche Médicale de Lambaréné
- Umea University
- Humboldt University
- University of Tuebingen
- University of Nagasaki
- Government of Madagascar
- Government of Netherlands
- Centre de Recherches Médicales de Lambaréné
- Vendsyssel Hospital
- K'Ola Vanona
Organization Involved with Phase 2 Indications (16)
- Immune Design
- Medical Research Council
- Albert Schweitzer Hospital
- Baylor University
- University of London
- Makerere University
- Rhode Island Hospital
- University of Liverpool
- Biomedical Research Center ESPOIR POUR LA SANTE
- Ministry of Health, Vector Control Division
- University of Sao Paulo
- George Washington University
- Orygen Biotecnologia SA
- Biomedical Research Center EPLS
- Johnson and Johnson
- Research Institute of Tropical Medicine, The Philippines
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (16)
- DSM
- Tropical Diseases Research Centre, Zambia
- National Institute for Medical Research, Tanzania
- Aarhus University
- Addis Ababa University
- Alexandria University
- Cairo University
- Catholic University of Health and Allied Sciences
- Menoufia University
- Sorlandet Hospital HF
- University of Oslo
- Statens Serum Institut
- University of Cambridge
- University of Agder
- High Institute of Public Health, Egypt
- Government of Uganda